DIAGNOSIS OF CHRONIC HEART FAILURE DOGS – EXISTING METHODS AND FUTURE PROSPECTS


  • R. Trofimjak Lviv national university of veterinary medicine and biotechnologies named after S. Gzhytskyj
  • L. Slivinska Lviv national university of veterinary medicine and biotechnologies named after S. Gzhytskyj
Keywords: chronic heart failure, dog, cardiac biomarkers, myocardium, cardiac troponin C, I and T

Abstract

The article analyzes the current scientific work related to the study of processes of chronic heart failure (CHF), and the use of biomarkers in the diagnosis of heart disease in dogs. Thoracic radiography, electrocardiography, and echocardiography are used to diagnose heart disease in dogs but despite the use of non–invasive methods, there is uncertainty about the severity of the disease and prognosis for each patient individually. In veterinary practice for the diagnosis of myocardial lesions in animals are clinically valuable, highly sensitive and simple to use cardiac biomarkers. A biomarker is typically a substance in the blood that can be objectively measured and indicates a biologic or pathologic process or response to therapy.1 There are scores of cardiac biomarkers,but this article will focus on the 2 most clinically useful ones in the dog and cat:cardiac troponin I (cTnI) and N–terminal pro–B–type natriuretic peptide (NT–proBNP). The cardiac troponins I, T, and C (cTnI, cTnT, and cTnC) are thin filament–associated regulatory proteins of the heart muscle. Cardiac troponin I («I» for inhibition) is uniquely expressed in the myocardium and is a potent inhibitor of the process of actin–myosin cross–bridge formation. The molecular weight is 24.000 D. Cardiac troponin T («T» for tropomyosin binding) has a molecular weight of 37.000 D and binds the troponin complex to tropomyosin. Cardiac troponin C («C» for calcium) binds to calcium and starts, therefore, the crossbridge cycle. As with cTnI, approximately 95% of cTnT in man and dogs is myofibril bound and about 5% is cytosolically dissolved. Mechanisms for an elevation in circulating cardiac troponins include an increase of myocyte membrane permeability (initial release of the cytosolic troponin pool) or cell necrosis (release of myofibrilbound troponins). Four to six hours after acute myocardial cell injury, the cardiac troponin concentration in blood increases in a biphasic pattern. Plasma half–life of cardiac troponins is approximately two hours, and elimination mainly occurs via the reticuloendothelial system (cTnI and cTnT) and renal loss (cTnT). Cardiac troponins are phylogenetically highly preserved proteins with a more than 95% total structural agreement between mammals. Therefore, established human serologic tests for troponin analysis may be used reliably in pets as well. Myocardial cell injury, manifested anatomically as inflammation (endomyocarditis, myocarditis, perimyocarditis), acute degeneration, apoptosis, or necrosis or hemodynamically as transient or permanent cardiac contractile dysfunction, is a frequent consequence of physical myocardial trauma (cardiac contusion), cardiomyopathy, metabolic or toxic myocardial damage (anthracyclines, catecholamines, bacterial endotoxins, tumor necrosis factor), myocardial ischemia or infarction. However, early diagnosis of myocardial injury may be important from a therapeutic and prognostic perspective.

 

Downloads

Download data is not yet available.

References

Rudenko, A.A., Cvіlіhovs'kij, M.І. (2009). Poshirenіst' ta etіologіchna struktura sercevo–sudinnih hvorob u sobak. Vet. Medicina Ukraїni. 10, 13–15 (in Ukrainian).

Nimand, H.G., Suter, P.B. (2001). Bolezni sobak. M: Akvarium (in Russian).

Mandigers, P.J., Senders, T., Rothuizen, J. (2006). Morbidity and mortality in 928 dobermanns in the Netherlands between 1993 and 1999. Vet.Res. 158, 7, 226–229.

Illarionova, V.K. (2010). Diagnostika boleznej serdca u sobak i koshek. M.: Kolos (in Russian).

Levchenko, V.І., Vlіzlo, V.V., Kondrahіn, І.P. ta іn. (2004). Klіnіchna dіagnostika vnutrіshnіh hvorob tvarin: pіdruchnik. Bіla Cerkva (in Ukrainian).

Maksimovich, І.A., Slіvіns'ka, L.G. (2013). Elektrokardіografіja v sobak: bіoelektrichna aktivnіst', provіdna sistema, osnovnі funkcії sercja. Veterinarna medicina ukraїni. 8 (210), 18–22 (in Ukrainian).

Pat.51272 Ukraіni, MPK A61V 5/0468. Sposіb elektrokardіografіchnoї dіagnostiki drіbnih tvarin/ Rudenko A.A. Rudenko P.A.; zajavnik і patentovlasnik Lugan.nac.agrar.un–t–№u201000293;zajavl 12.07.104 opubl. 12.07.10, Bjul № 13 (in Ukrainian).

Rudenko, A.A. (2008). Elektrokardіografіchnі markeri porushennja funkcії sercja u sobak. V kn.: Materіali IV mіzhnarodnoї nauk.–prakt. Konf. Z utrimannja, godіvlі ta lіkuvannja dikih tvarin, 16–18 kvіtnja 2008 r. K., 109–111 (in Ukrainian).

Pivnenko, T.V., Kartash, M.I. (2013). Jehokardiografija sobak s dilatacionnoj kardiomiopatiej. Naukovij vіsnik veterinarnoї medicini. 11, 125–128 (in Ukrainian).

Rudenko, A.A.. (2010). Rentgenokardіometrichnі pokazniki u klіnіchno zdorovih sobak. Vet.medicina: Mіzhvіd. Tematichnij nauk. Zb. 93, 334–339 (in Ukrainian).

Rejnol'ds, K., Ojjama, M. (2009). Biomarkery v diagnostike serdechnyh zabolevanij u sobak. Zhurnal Veterinary Focus. 18, 2–6.

Tilley, P.L., Francis, W.K., Smith, J., Oyama, M.A. (2008). Manual of canine and feline cardiology. Copyright by Saunders, an imprint of Elsevier Inc, 105–106 (Fourth edition).

Linklater, A.J., Lichtenberger, M.K., Thamm, D.H. (2007). Serum concentrations of cardiac troponin I and cardiac troponinT in dogs with class IV congestive heart failure due to mitral valve disease. Journal of Veterinary Emergency and Critical Care. 17, 243–249.

O’Brien, P.J., Reagan, W.J., York, M.J. (2011). Review of Qualification Data for Cardiac Troponins. Center for Drug Evaluation and Research U.S. Food and Drug Administration.

Lilly, L.S. (2003). Patophysiology of heart disease. Leonard. Lippincott Williams and Wilkins, 93–96.

Adams, J.E., Bodor, G.S., Davila–Roman, V.G. (1993). Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation. 88, 101–116.

DeFrancesko, T. (2011). Cardiac biomarkers. NAVC Clinician’s Brief, 15–19.

Schober, K.E., Kirbach, B., Cornand, C. (2001). Circulating cardiac troponins in small animals. Denver, 2–3.

Undhad, V.V., Fefar, D.T., Jivan, B.M. (2012). Cardiac troponin: an emerging cardiac biomarker in animal health. Vet. World. 5(8), 508–511.

Sleeper, M.M., Clifford, C.A., Laster, L.L. (2001). Cardiac Troponin I in the Normal Dog and Cat. Brief Communication J. Vet Intern Med. 15, 501–503.

Fox, P.R., Sisson, D., Sydney, N. (1999). Textbook of canine and feline cardiology, Principles and Clinical Practice. W.B. Saunders company, 10–11.

Oyama, M.A., Sisson, D.D. (2004). Cardiac troponin–I concentration in dogs with cardiac disease. J. Vet Intern Med. Nov–Dec; 18(6):831–9.

Abstract views: 94
PDF Downloads: 46
Published
2016-10-05
How to Cite
Trofimjak, R., & Slivinska, L. (2016). DIAGNOSIS OF CHRONIC HEART FAILURE DOGS – EXISTING METHODS AND FUTURE PROSPECTS. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences, 18(3(71), 130-133. https://doi.org/10.15421/nvlvet7129